Baxter Receives Tentative FDA Approvals For Ondansetron Injection In Vials And Premix Containers
Sat, 17 Jun 2006 06:00 AM EST
... Baxter HealthcareCorporation today announced that it has received tentative approvals fromthe U.S. Food and Drug Administration (FDA) for Ondansetron Injection USP,including the first tentative approval for a premix version ofGlaxoSmithKline's Zofran(R), which is used for the prevention of nausea andvomiting. [click link for full article] ...
Related Topics
- Ondansetron
- Cardiovascular Health
- Ondansetron Hydrochloride Injection (Home Infusion)
- Dicyclomine Injection
- Cortisone Injection
- Tacrolimus ointment
- Ondansetron Oral Solution
- Mammography
- Dimenhydrinate Injection
- Calcitonin Salmon Injection
- Sulfamethoxazole and Trimethoprim Injection
- Carcinogens
- Dexamethasone Injection
- Progesterone Injection
- Zidovudine Injection
- Pimecrolimus Cream 1%
- Ketorolac Injection
- Dietary Guidelines
- Heparin Injection
- Caffeine Injection

Not Signed In -


